Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Cancer Causes Control. 2012 Dec 28;24(3):421–426. doi: 10.1007/s10552-012-0127-3

Table 2.

Risk ratios for high level of basal E2 (> 48 pg/ml)

Risk Ratioa 95% Confidence Interval
Patients with BRCA gene mutation (n=29) 2.3 1.1 – 4.9
Patients with BRCA1 gene mutation (n=21) 2.3 1.0 – 5.6
Patients with BRCA2 gene mutation (n=8) 3.1 1.3 – 7.6

Abbreviation: E2, estradiol

a

Risk ratio for high level of basal E2 compared to patients without BRCA gene mutations after adjusting for age and BMI